Literature DB >> 18623128

Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan.

Chyong-Huey Lai1, Angel Chao, Chee-Jen Chang, Fang-Yu Chao, Huei-Jean Huang, Swei Hsueh, Cheng-Tao Lin, Hui-Hsin Cheng, Chu-Chun Huang, Jung-Erh Yang, Tzu-I Wu, Hung-Hsueh Chou, Ting-Chang Chang.   

Abstract

Human papillomavirus (HPV) persistence is essential for cervical cancer development. We accrued nested-cohort subjects from a population-based study to investigate the host and viral factors related to outcome of HPV infection. Women (age > or = 30 years old) with HPV-positive but normal cytology and negative colposcopy were invited to participate. After signing informed consent, every participant completed a structured questionnaire and had 6-monthly follow-ups of Pap smear, HPV testing and colposcopy. Total and type-specific HPV clearance rates as well as host and viral factors associated with clearance in 3-year longitudinal follow-up were analyzed. Adjusted hazard ratios (HRs) of progression to > or = cervical intraepithelial neoplasia (CIN) 2 according to baseline HPV of the women with normal cytology were calculated from national registry database. Among the 626 eligible women, 526 (median age 47, 29-75) were enrolled and 412 returned for follow-up at least once. The median follow-up of enrolled subjects was 23 months (range 6.8-39). The 3-year cumulative total HPV clearance rate was 49.0% (95% confidence interval [CI]: 43.3-54.7%). The median 3-year cumulative type-specific HPV clearance rate was 50.0% (range 0-100.0%) with a median time to clearance of 12.4 months (6.4-24.5). Older age was associated with significantly decreased total HPV clearance and decreased type-specific clearance in HPV-18 and -53, while high viral load was associated with decreased total and type-specific clearance. After adjusting confounding variables, the HR of developing > or =CIN2 in baseline HPV-positive women was 34.0-fold (95% CI: 15.5-74.7) as compared to HPV-negative women.

Entities:  

Mesh:

Year:  2008        PMID: 18623128     DOI: 10.1002/ijc.23679

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Authors:  Arati Mane; Vikrant V Sahasrabuddhe; Amit Nirmalkar; Arun R Risbud; Seema Sahay; Ramesh A Bhosale; Sten H Vermund; Sanjay M Mehendale
Journal:  J Clin Virol       Date:  2016-10-28       Impact factor: 3.168

2.  Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Authors:  Tsung-chieh Jane Fu; Long Fu Xi; Ayaka Hulbert; James P Hughes; Qinghua Feng; Stephen M Schwartz; Stephen E Hawes; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

3.  Optimal positive cutoff points for careHPV testing of clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural China.

Authors:  Le-Ni Kang; Jose Jeronimo; You-Lin Qiao; Fang-Hui Zhao; Wen Chen; Melissa Valdez; Xun Zhang; Pooja Bansil; Proma Paul; Ping Bai; Roger Peck; Jing Li; Feng Chen; Mark H Stoler; Philip E Castle
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

4.  Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.

Authors:  Long Fu Xi; James P Hughes; Philip E Castle; Zoe R Edelstein; Chunhui Wang; Denise A Galloway; Laura A Koutsky; Nancy B Kiviat; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-03-16       Impact factor: 5.226

5.  Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study.

Authors:  Karolina Louvanto; Kari J Syrjänen; Marjut A M Rintala; Seija E Grénman; Stina M Syrjänen
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

Review 6.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

7.  Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up.

Authors:  Long Fu Xi; James P Hughes; Zoe R Edelstein; Nancy B Kiviat; Laura A Koutsky; Constance Mao; Jesse Ho; Mark Schiffman
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

8.  Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.

Authors:  Rachel L Winer; Long Fu Xi; Zhenping Shen; Joshua E Stern; Laura Newman; Qinghua Feng; James P Hughes; Laura A Koutsky
Journal:  Int J Cancer       Date:  2013-10-18       Impact factor: 7.396

9.  Human papillomavirus persistence in young unscreened women, a prospective cohort study.

Authors:  Channa E Schmeink; Willem J G Melchers; Albertus G Siebers; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

10.  Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.

Authors:  Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.